Concr Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Concr Limited - overview
Established
2018
Location
London, -, UK
Primary Industry
Software
About
Based in London, UK, and founded in 2018, Concr Limited operates as a healthcare technology firm. The company was founded by its CEO, Matt Foster, CTO, Matthew Griffiths, and CSO, Uzma Asghar. In March 2023, Concr Limited raised GBP 1. 22 million in seed funding, co-led by SyndicateRoom, Cambridge Enterprise, Cambridge Angels Group, and R42.
Concr provides FarrSight, which is an online platform that analyzes data sets and stores cancer-related data in a single location that can be used for drug development and patient treatment. The company leverages statistical modeling and machine learning algorithms to analyze and integrate data from diverse sources, including in-vitro models and cancer biopsies. The company plans to use the funds raised in March 2023 to support further product development and expand its portfolio in the pharmaceutical line.
Current Investors
Cambridge Enterprise, Cambridge Angels Group, SyndicateRoom
Primary Industry
Software
Sub Industries
Healthcare IT, Pharmaceutical Research & Development, Medical Software, Application Integration Software, Analytics & Performance Software
Website
www.concr.co
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.